about
Detection and identification of potential biomarkers of non-small cell lung cancer.Detection of pre-invasive lung cancer: technical aspects of the LIFE project.Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancerIdentification of an autoantibody panel to separate lung cancer from smokers and nonsmokersCT scan screening is associated with increased distress among subjects of the APExSThe potential for using risk models in future lung cancer screening trials.Offering lung cancer screening to high-risk medicare beneficiaries saves lives and is cost-effective: an actuarial analysis.A multi-analyte serum test for the detection of non-small cell lung cancer.CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort.Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancerAvailable treatment options for the management of Lambert-Eaton myasthenic syndrome.Healthcare use after screening for lung cancer.UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer.Urinary protein biomarkers in the early detection of lung cancer.Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.An epigenetic marker panel for detection of lung cancer using cell-free serum DNA.A computerized scheme for lung nodule detection in multiprojection chest radiographyCirculating microRNAs: next-generation biomarkers for early lung cancer detection.Metformin inhibits growth of lung adenocarcinoma cells by inducing apoptosis via the mitochondria-mediated pathway.Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma.Serum biomarker profiles as diagnostic tools in lung cancer.Developing a complex intervention to reduce time to presentation with symptoms of lung cancerSmoking and lung cancer-induced changes in N-glycosylation of blood serum proteins.Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbonsChromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer.Pazopanib for Non-small Cell Lung Cancer: The First Case Report in Korea.Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2.Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.S-adenosylmethionine as a biomarker for the early detection of lung cancerMonocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivoMitochondrial DNA copy number and exposure to polycyclic aromatic hydrocarbonsTumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers.CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.Aberrant promoter methylation of hOGG1 may be associated with increased risk of non-small cell lung cancer.Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer.Early detection and screening of lung cancer.New biomarkers for lung cancer.Issues with implementing a high-quality lung cancer screening program.Identification of featured biomarkers in different types of lung cancer with DNA microarray.Detecting small lung tumors in mouse models by refractive-index microradiology.
P2860
Q30898054-A00CD72E-B946-4BBC-88F4-5D0329189424Q33275734-3073B137-A465-4275-B1C0-11B28607881CQ33472669-11B16A2E-5D6B-4B92-A68D-1A540140C2E4Q33588113-01C56A45-852C-43EE-BD1D-A25EF9E166EAQ33729181-6D7380FF-FEFE-443E-91D4-AF1E674607C8Q34175634-8EAF6C27-D5FB-40E1-99F8-E0E798FB9FDAQ34179454-9BD87281-EB10-48F9-9D34-18D25EEFA13DQ34255948-564A39A3-96C5-4FFF-B6C6-85B4926EA09FQ34328947-A62137DD-F3FE-4E51-A5ED-9C05115D76D9Q34407180-9451872B-0E28-4C7C-8D30-FB73C4DF4030Q34542581-20015CB9-DCC6-4F33-8819-17F349427F29Q34707733-E82BF1B9-B179-44D3-ADF5-E834B5779E8DQ34714126-1AFFE18D-6ACE-49B5-A60F-0768C967F6B2Q35044516-5DC8A687-8E77-4BA9-8D8D-79D27D9E0EA4Q35051751-75E3DD01-AC4C-407D-BB66-D54E89CF1677Q35091230-2CBEB29C-DAE5-45A7-A25C-7D2DD9A85BFAQ35874636-DBB7F344-1BC4-45A9-8797-704C813FA5F3Q35883222-415BD04B-6F32-4BA3-B332-8C8C15C12762Q35944480-2AFBEBB3-E5BD-428E-B2F8-F85BC1156DC0Q35964491-EC063B55-FDD2-4B8E-A0CE-407CA6A3DE8AQ36016138-D03BA8F7-1D6F-43EB-86C0-B378085F08ADQ36185795-ED456E05-045F-4E0E-B2CB-F600CFE848C0Q36362594-98A8379F-8391-4673-8208-6D9AF60C07E9Q36379051-63F46950-85C6-4AC7-9FBB-7AD44789E97CQ36414871-4C1ACC90-8218-4C6B-BCF6-916334D84475Q36482433-B2A33BB6-8687-49B5-8D5A-C7E54FA95178Q36642328-7F15B305-4FAE-4B85-B240-00BFC6F82902Q36661979-677C81A9-5B99-476E-A9D7-FF31991696D2Q36926001-8B7981B1-F7B0-49C1-B1A8-B3E5AA8A77D5Q37109532-EE4F04C9-018E-4A56-8F43-55ED6B1CDF2FQ37238023-1DAB70AB-FE13-4A1B-9301-16D38EB06F62Q37553893-5F87CB45-606E-4BC4-A7C1-41F1665B6C63Q37624627-EE2D88E5-6BB0-4502-80BC-3DF2DFAF3267Q37702708-5AAF68A6-2556-4DE8-96AA-77F652570C6CQ37745875-8E0EC370-A320-45F0-BE10-B46C29DC400EQ37789035-60103E56-6345-4D25-8E2E-329F5F65C055Q38089079-A2260937-E338-4D17-B21F-51F9BA6A05C0Q38224354-B9F9C4F0-7C3D-4B9B-913B-1677003CD2AAQ39163278-6EB336B4-59E6-4B67-94FC-D3E764FBEA00Q39533362-3D6BA160-D673-4520-B58F-41475AF3E733
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Clinical practice. Lung cancer screening.
@ast
Clinical practice. Lung cancer screening.
@en
type
label
Clinical practice. Lung cancer screening.
@ast
Clinical practice. Lung cancer screening.
@en
prefLabel
Clinical practice. Lung cancer screening.
@ast
Clinical practice. Lung cancer screening.
@en
P356
P1476
Clinical practice. Lung cancer screening.
@en
P2093
Daniel C Sullivan
James L Mulshine
P304
P356
10.1056/NEJMCP042630
P407
P577
2005-06-01T00:00:00Z